RU2018105091A3 - - Google Patents

Info

Publication number: RU2018105091A3
Authority: RU; Russia

Application number

RU2018105091A

Other versions

RU2018105091A (ru

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-07-13

Filing date

2016-07-13

Publication date

2019-08-13

2016-07-13 Application filed filed Critical

2019-08-13 Publication of RU2018105091A3 publication Critical patent/RU2018105091A3/ru

2019-08-13 Publication of RU2018105091A publication Critical patent/RU2018105091A/ru

2019-09-03 Application granted granted Critical

2019-09-03 Publication of RU2699027C2 publication Critical patent/RU2699027C2/ru

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/06—Implements for therapeutic treatment
- A61C19/08—Implements for therapeutic treatment combined with anaesthetising implements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Birds (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Gerontology & Geriatric Medicine (AREA)
Dentistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

RU2018105091A 2015-07-13 2016-07-13 Ретиноидные композиции для местного применения RU2699027C2 (ru)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201562191937P	2015-07-13	2015-07-13
US62/191,937		2015-07-13
PCT/US2016/042168 WO2017011600A1 (en)	2015-07-13	2016-07-13	Topical retinoid compositions

Publications (3)

Publication Number	Publication Date
RU2018105091A3 true RU2018105091A3 (ru)	2019-08-13
RU2018105091A RU2018105091A (ru)	2019-08-13
RU2699027C2 RU2699027C2 (ru)	2019-09-03

Family

ID=56550383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2018105091A RU2699027C2 (ru)	2015-07-13	2016-07-13	Ретиноидные композиции для местного применения

Country Status (15)

Country	Link
US (5)	US9707216B2 (ru)
EP (1)	EP3322401A1 (ru)
JP (1)	JP6666992B2 (ru)
KR (1)	KR20180026740A (ru)
CN (1)	CN108024954A (ru)
AU (1)	AU2016294504B2 (ru)
BR (1)	BR112018000734A2 (ru)
CA (1)	CA2992107A1 (ru)
CO (1)	CO2018001375A2 (ru)
EA (1)	EA034808B1 (ru)
MX (1)	MX2018000421A (ru)
NZ (1)	NZ738815A (ru)
RU (1)	RU2699027C2 (ru)
WO (1)	WO2017011600A1 (ru)
ZA (1)	ZA201800080B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en)	2007-12-07	2009-07-23	Foamix Ltd.	Oil and liquid silicone foamable carriers and formulations
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es)	2009-10-02	2018-10-12	Foamix Pharmaceuticals Ltd	Composiciones tópicas de tetraciclina.
RU2699027C2 (ru) *	2015-07-13	2019-09-03	Др. Редди'С Лабораториз Лтд.	Ретиноидные композиции для местного применения
US10398641B2 (en)	2016-09-08	2019-09-03	Foamix Pharmaceuticals Ltd.	Compositions and methods for treating rosacea and acne
US9987239B1 (en) *	2017-03-14	2018-06-05	Rey Ventures, LLC	Pharmaceutical retinoid preparation for topical use
WO2019068096A1 (en)	2017-09-29	2019-04-04	Rodan & Fields, Llc	COMPOSITIONS CONTAINING RETINALDEHYDE AND METHODS OF USE
US10653656B2 (en) *	2018-04-05	2020-05-19	Bausch Health Ireland Limited	Topical pharmaceutical compositions for treating skin conditions
US20210369586A1 (en) *	2018-10-19	2021-12-02	Topix Pharmaceuticals, Inc.	Retinol formulations and skin treatment methods thereof
CN112386565B (zh) *	2019-08-02	2024-09-13	北京盈科瑞创新医药股份有限公司	一种马钱子碱凝胶制剂及其制备方法
MX2022002204A (es)	2019-08-22	2022-03-11	Advansix Resins & Chemicals Llc	Derivados de siloxano de aminoacidos que tienen propiedades activas de superficie.
MX2022007424A (es) *	2019-12-20	2022-09-19	Advansix Resins & Chemicals Llc	Tensioactivos para uso en productos para el cuidado de la salud.
JP7451717B2 (ja)	2019-12-31	2024-03-18	アドバンシックス・レジンズ・アンド・ケミカルズ・リミテッド・ライアビリティ・カンパニー	油及びガス生産のための界面活性剤
US20220233489A1 (en) *	2021-01-28	2022-07-28	Chemistryrx	Kits for dermal care
DE102022212093A1 (de) *	2022-11-15	2024-05-16	Beiersdorf Aktiengesellschaft	Waschformulierung gegen Akne
FR3147098A1 (fr) *	2023-03-28	2024-10-04	L'oreal	Composition à deux phases

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3965275A (en) *	1974-02-11	1976-06-22	Commercial Solvents Corporation	Composition and method
FR2350095A1 (fr) *	1976-05-03	1977-12-02	Oreal	Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4154823A (en) *	1976-06-10	1979-05-15	Schutt Steven R	Skin treatment compositions and methods of using same
GB9409778D0 (en) *	1994-05-16	1994-07-06	Dumex Ltd As	Compositions
US5445823A (en) *	1994-10-20	1995-08-29	The Procter & Gamble Company	Dermatological compositions and method of treatment of skin lesions therewith
US5690947A (en) *	1996-08-30	1997-11-25	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US6338855B1 (en)	1996-10-25	2002-01-15	The Procter & Gamble Company	Cleansing articles for skin and/or hair which also deposit skin care actives
US5855893A (en)	1997-02-14	1999-01-05	Elizabeth Arden Co., Division Of Conopco, Inc.	Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
JP4387463B2 (ja)	1997-02-20	2009-12-16	アラーガン、インコーポレイテッド	タザロテンおよびコルチコステロイドによる乾癬の処置
ATE226064T1 (de) *	1997-09-12	2002-11-15	Procter & Gamble	Hautreinigungs- und konditionierungsartikel für haut und haar
US6036963A (en) *	1998-02-26	2000-03-14	Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc.	Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
EP1100490B1 (en) *	1998-07-28	2006-12-13	Susan Bershad	Short contact treatment of acne and photoaging with topical retinoids
US6017938A (en)	1998-07-28	2000-01-25	Bershad; Susan	Short contact treatment for acne
FR2787322B1 (fr) *	1998-12-18	2002-10-18	Galderma Res & Dev	Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
JP2000212082A (ja)	1999-01-26	2000-08-02	Showa Denko Kk	皮膚用剤
US6114348A (en) *	1999-03-10	2000-09-05	Weber; Paul J.	Method of treating warts using tazarotene
US6277881B1 (en) *	1999-05-27	2001-08-21	Unilever Home & Personal Care, Usa, Division Of Conopco, Inc.	Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6385623B1 (en) *	1999-11-12	2002-05-07	Dell Usa, L.P.	System and method for ensuring proper execution of scheduled file updates
US6387383B1 (en)	2000-08-03	2002-05-14	Dow Pharmaceutical Sciences	Topical low-viscosity gel composition
US6495602B1 (en) *	2001-12-13	2002-12-17	Bradley Pharmaceuticals, Inc.	Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US20050205086A1 (en) *	2002-10-25	2005-09-22	Foamix Ltd.	Retinoid immunomodulating kit and composition and uses thereof
US20060233721A1 (en) *	2002-10-25	2006-10-19	Foamix Ltd.	Foam containing unique oil globules
US6974570B1 (en) *	2002-10-30	2005-12-13	Griffith Dana K	Shaving lotion kit and method of preparing skin and unwanted hair for shaving
NZ541526A (en) *	2003-01-24	2008-03-28	Stiefel Res Australia Pty Ltd	Clindamycin phosphate foam
US7169401B2 (en) *	2003-07-18	2007-01-30	Hill Dermaceuticals, Inc.	Topical skin care composition containing refined peanut oil
AU2004261063A1 (en)	2003-08-04	2005-02-10	Foamix Ltd.	Foam carrier containing amphiphilic copolymeric gelling agent
FR2871377B1 (fr)	2004-06-11	2007-08-24	Galderma Res & Dev	Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
US20080132580A1 (en)	2004-12-17	2008-06-05	Mandavilli Sarveswara Rao Srir	Dispersion For Delivering Active Agents
FR2894821B1 (fr) *	2005-12-15	2008-02-29	Galderma Res & Dev	Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
FR2920967B1 (fr) *	2007-09-14	2009-10-23	Sederma Soc Par Actions Simpli	Utilisation de l'hydroxymethionine en tant qu'actif anti age
BRPI1008037B1 (pt) *	2009-02-25	2019-08-06	Stiefel Research Australia Pty Ltd.	Composição de espuma aerossol de emulsão de óleo em água, uso da dita composição para o tratamento de uma doença, distúrbio ou condição da pele e processo para a preparação da dita composição
PT3310389T (pt) *	2015-06-18	2020-11-11	Valeant Pharmaceuticals North America	Composições tópicos compreendendo um corticosteroide e um retinoide para o tratamento da psoríase
RU2699027C2 (ru) *	2015-07-13	2019-09-03	Др. Редди'С Лабораториз Лтд.	Ретиноидные композиции для местного применения

2016
- 2016-07-13 RU RU2018105091A patent/RU2699027C2/ru active
- 2016-07-13 EA EA201890218A patent/EA034808B1/ru not_active IP Right Cessation
- 2016-07-13 CA CA2992107A patent/CA2992107A1/en not_active Abandoned
- 2016-07-13 NZ NZ73881516A patent/NZ738815A/en not_active IP Right Cessation
- 2016-07-13 US US15/209,716 patent/US9707216B2/en not_active Expired - Fee Related
- 2016-07-13 WO PCT/US2016/042168 patent/WO2017011600A1/en not_active Ceased
- 2016-07-13 JP JP2018501272A patent/JP6666992B2/ja not_active Expired - Fee Related
- 2016-07-13 AU AU2016294504A patent/AU2016294504B2/en not_active Ceased
- 2016-07-13 CN CN201680045720.7A patent/CN108024954A/zh active Pending
- 2016-07-13 MX MX2018000421A patent/MX2018000421A/es unknown
- 2016-07-13 EP EP16742531.3A patent/EP3322401A1/en not_active Withdrawn
- 2016-07-13 KR KR1020187003169A patent/KR20180026740A/ko not_active Ceased
- 2016-07-13 BR BR112018000734A patent/BR112018000734A2/pt not_active IP Right Cessation
2017
- 2017-06-13 US US15/621,325 patent/US9931328B2/en not_active Expired - Fee Related
2018
- 2018-01-05 ZA ZA2018/00080A patent/ZA201800080B/en unknown
- 2018-02-12 CO CONC2018/0001375A patent/CO2018001375A2/es unknown
- 2018-02-22 US US15/902,635 patent/US10716781B2/en not_active Expired - Fee Related
2019
- 2019-03-29 US US16/369,320 patent/US11026934B2/en not_active Expired - Fee Related
2021
- 2021-02-08 US US17/170,161 patent/US20210161875A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN108024954A (zh)	2018-05-11
AU2016294504B2 (en)	2019-07-18
CA2992107A1 (en)	2017-01-19
JP2018524366A (ja)	2018-08-30
US20180177774A1 (en)	2018-06-28
US20210161875A1 (en)	2021-06-03
US9707216B2 (en)	2017-07-18
US10716781B2 (en)	2020-07-21
BR112018000734A2 (pt)	2018-09-04
AU2016294504A1 (en)	2018-01-25
JP6666992B2 (ja)	2020-03-18
RU2699027C2 (ru)	2019-09-03
EP3322401A1 (en)	2018-05-23
CO2018001375A2 (es)	2018-06-20
US20170281610A1 (en)	2017-10-05
MX2018000421A (es)	2018-05-17
NZ738815A (en)	2019-10-25
EA034808B1 (ru)	2020-03-24
US11026934B2 (en)	2021-06-08
US20170014398A1 (en)	2017-01-19
US20190224181A1 (en)	2019-07-25
RU2018105091A (ru)	2019-08-13
ZA201800080B (en)	2020-02-26
EA201890218A1 (ru)	2018-09-28
KR20180026740A (ko)	2018-03-13
US9931328B2 (en)	2018-04-03
WO2017011600A1 (en)	2017-01-19

Publication	Publication Date	Title
RU2018105091A3 (ru)	2019-08-13
BE2015C047I2 (ru)	2022-08-10
BE2015C044I2 (ru)	2023-08-31
BR0009349B1 (ru)	2015-08-18
BR0009373B1 (ru)	2015-09-01
BR0000126B1 (ru)	2015-07-14
BR0000695B1 (ru)	2015-07-21
BR0000763F1 (ru)	2015-09-15
BR0001536B1 (ru)	2015-09-29
BR0001684B1 (ru)	2015-04-22
BR0001810B1 (ru)	2015-06-23
BR0002033B1 (ru)	2015-06-09
BR0002402B1 (ru)	2015-08-11
BR0002435B1 (ru)	2015-05-19
BR0002694B1 (ru)	2015-08-04
BR0002802B1 (ru)	2015-03-31
BR0002874B1 (ru)	2015-09-01
BR0003166B1 (ru)	2015-08-25
BR0003189B1 (ru)	2015-03-24
BR0003208B1 (ru)	2015-03-17
BR0003401B1 (ru)	2015-08-25
BR0003686B1 (ru)	2015-08-18
BR0003746B1 (ru)	2015-08-25
BR0003751B1 (ru)	2015-08-11
BR0003928B1 (ru)	2015-09-15